期刊文献+

左西孟旦对去甲肾上腺素诱导的心肌细胞钙瞬变信号的影响 被引量:2

Effects of levosimendan on calcium transient in norepinephrine-cultured neonatal rat ventricular myocytes
下载PDF
导出
摘要 目的 :研究心肌细胞衰竭过程中钙瞬变信号的变化及左西孟旦(levosimendan,LeV)对其影响。方法 :培养Sprague Dawley(SD)乳大鼠心肌细胞48 h后,分为对照组、去甲肾上腺素(NE)组、NE+LeV1(0.1μmol/L)诱导组和NE+LeV2(1μmol/L)诱导组。NE组以去甲肾上腺素10μmmol/L诱导;NE+LeV1组先用NE诱导,再以LeV 0.1μmol/L干预;NE+LeV2组先用NE诱导,再以LeV 1μmol/L干预。用Ca^(2+)荧光指示剂Fluo-3/AM负载心肌细胞,激光共聚焦显微镜观察心肌细胞钙瞬变信号变化以及心肌细胞的搏动频率。结果:1与对照组相比,NE组心室肌细胞钙波分散、传导减慢、同步性较差,细胞搏动频率较快(26.7±4.3 vs.11.6±3.6,P<0.01)、收缩期钙瞬变峰值下降(128.37±65.44 vs.155.33±61.77,P<0.05)、达峰时间(Ttp,0.413±0.324 vs.0.212±0.050,P<0.01)、衰减时间(Tau,1.162±0.524 vs.0.722±0.169,P<0.01)均延长,钙瞬变幅度(60.80±39.88vs.75.41±36.52,P>0.05)、谷值(67.57±42.59 vs.79.92±38.05,P>0.05)变化不大;2 LeV处理后,钙波传导均匀同步,心肌细胞搏动频率及钙瞬变的峰值、幅度、谷值较NE组无明显变化,NE+LeV1组和NE+LeV2组Ttp分别为(0.212±0.044、0.205±0.062)、Tau分别为(0.735±0.269、0.753±0.152)均较NE组缩短(P<0.01);3NE+LeV1与NE+LeV2两组相比,钙瞬变峰值和谷值、钙瞬变幅度、Ttp和Tau差别无统计学意义。结论:心肌细胞衰竭过程中钙瞬变减弱变慢、同步性较差;LeV通过增加钙瞬变速度、改善钙瞬变传导形式,发挥正性肌力作用。 Objective:To explore the alterations of the cal cium transient in the development of heart failure,and the impact of levosimendan(LeV)on intracellular Ca^(2+) dynamics. Methods:The neonatal rat ventricular myocytes in culture were divided into 4groups,normal,NE alone(10 μmol / L),NE+LeV1(0.1 μmmol / L), and NE+LeV2(1 μmmol / L). Calcium transients of myocytes loaded by Fluo-3 / AM were observed under Laser scanning confocal microscope. Results:(1)Compared with the control,calcium wave dispersed,conducted slowly,and exibited dyssynchrony of Ca^(2+)release in NE group,NE accelerated the cultured cell beating rate(26.7 ± 4.3 vs. 11.6 ± 3.6,P〈0.01),decreased peak systolic Ca^(2+)(128.37 ± 65.44 vs. 155.33 ± 61.77,P〈0.05),shortened time to peak(Ttp;0.413 ± 0.324 vs. 0.212 ± 0.050,P〈0.01)and decay time(Tau;1.162 ± 0.524 vs. 0.722 ± 0.169,P〈0.01)of calcium transient,except Ca^(2+) transient amplitude and resting Ca^(2+).(2)NE in the presence of LeV increased synchrony of calcium transient,reduced Ttp(0.212 ± 0.044 vs. 0.413 ± 0.324,NE+LeV1 vs. NE,P〈0.01 and 0.205 ± 0.062 vs. 0.413 ± 0.324,NE +LeV2 vs. NE,P〈0.01 respectively)and Tau(0.735 ± 0.269 vs. 1.162 ± 0.524,NE +LeV1 vs. NE,P〈0.01; and 0.753 ± 0.152 vs. 1.162 ± 0.524,NE+ LeV2 vs. NE,P〈0.01),had no effect on cell beating rate,peak systolic or resting Ca^(2+),and transient amplitude.(3)There were no concentration difference in the presence of Levosimendan. Conclusion:Our results show that calcium transient gets weaker and slower,exibiting dyssynchrony of Ca^(2+)release in failing rat ventricular myocyte. Levosimendan exerts positive inotropic effect through accelerating the velocity of calcium signaling propagation and synchronzing the calcium release.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2016年第2期166-170,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省"六大人才高峰"项目(No2015-WSN-004)
关键词 左西孟旦 去甲肾上腺素 乳鼠心肌细胞 钙瞬变信号 levosimendan norepinephrine the neonatal rat ventricular myocyte calcium transient
  • 相关文献

参考文献20

  • 1杨晓慧,卢新政.心肌细胞钙瞬变信号的研究进展[J].国际心血管病杂志,2009,36(4):215-218. 被引量:3
  • 2Antoniades C,Tousoulis D,Koumallos N,et al. Levosi- mendan:beyond its simple inotropic effect in heart fail- ure [ J ]. Pharmacol Ther, 2007,114 (2) : 184-197.
  • 3Moreno N,Tavares-Silva M,Lourenco AP,et al. Levosi- mendan:The current situation and new prospects[J]. Rev Port Cardiol, 2014,33 (12) :795-800.
  • 4Sorsa Tia, Pollesello Piero, Rosevear Paul, et al. Stereose- lective binding of levosimendan to cardiac troponin C causes Ca2+-sensitization[J]. Eur J Pharmacol,2004,486 (1):1-8.
  • 5Husebye T,Eritsland J, Muller C,et al. Levosimendan in acute heart failure following primary percutaneous coro- nary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial:a randomized, placebo-controlled study [J]. Eur J Heart Fail,2013,15 (5) :565-572.
  • 6Givertz MM, Andreou C, Conrad CH, et al. Direct myocar- dial effects of levosimendan in humans with left ventricu- lar dysfunction:alteration of force-frequency and relax- ation-frequency relationships [J]. Circulation,2007,115 (10) : 1218-1224.
  • 7Nieminen MS,Altenberger J,Ben-Gal T,et al. Repetitive use of levosimendan for treatment of chronic advanced heart failure :clinical evidence,practical considerations, and perspectives:an expert panel consensus [J]. Int J Cardiol,2014, 174(2) :360-367.
  • 8Mann DL, Kent RL, Parsons B, et al. Adrenergic effects on the biology of the adult mammalian cardiocyte[J]. Circu- lation, 1992,85(2) : 790-804.
  • 9Mork HK, Sjaastad I, Sejersted OM, et al. Slowing of car- diomyocyte Ca2+ release and contraction during heart fail- ure progression in postinfarction mice[J]. Am J Physiol Heart Circ Physiol, 2009,296(4) : H1069-H1079.
  • 10Thandapilly Sijo J,Louis Xavier L,Yang Tonghua,et al.Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes,by activating NO-AMPK pathway [ J ]. Eur J Pharmacol, 2011,668 (1-2) : 217-224.

二级参考文献25

  • 1Woo SH,Cleemann L,Morad M.Spatiotemporal characteristics ofjunctional and nonjunctiona focal Ca^2+ release in rat atrial myocytes[J].Circ Res,2003,92(1):e1-e11.
  • 2Vinogradova TM,Zhou YY,Maltsev V0 et al.Rhythmic ryanodine receptor Ca^2+ releases during diastolic depolarization of sinoatrial pacemaker cells do not require membrane depolarization[J].Circ Res,2004,94(6):802-809.
  • 3Shen JX,Wang S,Song LS,et al.Polymorphism of Ca^2+ sparks evoked from in-focus Ca2+ release units in cardiac myocytes[J].Biophys J,2004,86(1Ptl):182-190.
  • 4Jiang D,Xiao B,Yang D,et al.RyR2 mutation linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca^2+ release (SOICR)[J].Proc Narl Acad Sci USA,2004,101 (35):13062-13067.
  • 5Keller M,Kao JP,Egger M,et al.Calcium waves driven by "sensitization" wave-fronts[J].Cardiorasc Res,2007,74(1):39-45.
  • 6Wang SQ,Song LS,Lakatta EG,et al.Ca^2+ signalling between single L-type Ca2+ channels and ryanodine receptors in heart cells[J].Nature,2001,410 (6828):592-596.
  • 7Brochet DX,Yang D,Di Maio A,et al.Ca^2+ blinks:Rapid nanoscopic store calcium Signaling[J].Proc Natl Acad Sci USA,2005,102(8):3099-3104.
  • 8Onohara N,Nishida M,Inoue R,et al.TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy[J].EMBO J,2006,25(22):5305-5316.
  • 9Seth M,Sumbilla C,Mullen SP,et al.Sarco(endo)plasmic reticulum Ca^2+ ATPase (SERCA) gene silencing and remodeling of the Ca^2+ signaling mechanism in cardiac myocytes[J].Proc Natl Acad Sci USA,2004,101 (47):16683-16688.
  • 10Gyorke I,Hester N,Jones LR,et al.The role of calsequestrin,triadin,andjunctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium[J].Biophys J,2004,86(4):2121-2128.

共引文献2

同被引文献27

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部